Average Co-Inventor Count = 7.84
ph-index = 7
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Enanta Pharmaceuticals, Inc. (28 from 291 patents)
2. Elmore Patent Law Group, P.c. (1 from 1 patent)
29 patents:
1. 12459923 - Tetrazole containing apoptosis signal-regulating kinase 1 inhibitors and methods of use thereof
2. 12384753 - 17-beta-hydroxysteroid dehydrogenase type 13 inhibitors and methods of use thereof
3. 12018017 - Apoptosis signal-regulating kinase 1 inhibitors and methods of use thereof
4. 11958879 - Bile acid derivatives as FXR/TGR5 agonists and methods of use thereof
5. 11834436 - Tetrazole containing apoptosis signal-regulating kinase 1 inhibitors and methods of use thereof
6. 11560368 - Apoptosis signal-regulating kinase 1 inhibitors and methods of use thereof
7. 11466033 - Substituted pyridines as apoptosis signal-regulating kinase 1 inhibitors
8. 11420976 - Heterocyclic compounds as anti-viral agents
9. 11345699 - Apoptosis signal-regulating kinase 1 inhibitors and methods of use thereof
10. 11040998 - Bile acid derivatives as FXR/TGR5 agonists and methods of use thereof
11. 11008304 - Tetrazole containing apoptosis signal-regulating kinase 1 inhibitors and methods of use thereof
12. 10988458 - Apoptosis signal-regulating kinase 1 inhibitors and methods of use thereof
13. 10968199 - Cycloalkyl-containing apoptosis signal-regulating kinase 1 inhibitors and methods of use thereof
14. 10961272 - Process for preparation of sulfonyl carbamate bile acid derivatives
15. 10683279 - Apoptosis signal-regulating kinase 1 inhibitors and methods of use thereof